2608 Erwin Road Lakeview Pavi, Durham, NC 27705
Box 3527 Med Ctr, Durham, NC 27710
Scott H. Kollins, PhD received his undergraduate degree in psychology from Duke and his Master’s and Doctorate degrees in Clinical Psychology from Auburn University. After completing his clinical internship at the University of Mississippi Medical Center, where he served as Chief Intern, he joined the faculty of the Department of Psychology at Western Michigan University for three years, before joining the Duke faculty in 2000. Dr. Kollins has published more than 125 scientific papers in peer-reviewed journals. Over the past 10 years, his research has been supported by 6 different federal agencies, including NICHD, NIDA, NIMH, NIEHS, NINDS, and EPA, and he currently holds a mid-career K24 award from NIDA. He has also served as PI on more than 40 industry-funded clinical trials and is a consultant to a number of pharmaceutical companies in the area of ADHD clinical psychopharmacology. He has served as a standing member of the Child Psychopathology and Developmental Disabilities study section and also served as an ad-hoc reviewer for 10 additional NIH study sections and 7 international granting agencies. He is an Associate Editor for the Journal of Attention Disorders and has reviewed for more than 50 different peer-reviewed journals. He is an elected member of the College on Problems of Drug Dependence and the American College of Neuropsychopharmacology. Dr. Kollins is a licensed clinical psychologist and maintains a practice through the ADHD Program’s outpatient clinic. His research interests are in the areas of psychopharmacology and the intersection of ADHD and substance abuse, particularly cigarette smoking.
A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trialRead Full Text
Increased subjective and reinforcing effects of initial nicotine exposure in young adults with attention deficit hyperactivity disorder (ADHD) compared to matched peers: results from an experimental model of first-time tobacco use.
Associations between attention deficit hyperactivity disorder symptoms and eating behaviors in early childhood.
Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Titration Study of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR) in Preschool Children with Attention-Deficit/Hyperactivity Disorder.
Editorial: From risk prediction to action: leveraging electronic health records to improve pediatric population mental health.
Effect of Prenatal Smoke Exposure on Birth Weight: The Moderating Role of Maternal Depressive Symptoms.
Sleep/Wake Regularity Associated with Default Mode Network Structure among Healthy Adolescents and Young Adults.
Cannabis use is associated with potentially heritable widespread changes in autism candidate gene DLGAP2 DNA methylation in sperm.
Smoking abstinence effects on emotion dysregulation in adult cigarette smokers with and without attention-deficit/hyperactivity disorder.
Snacking frequency and dietary intake in toddlers and preschool children.
Corrigendum: Cigarette Smoking Progression Among Young Adults Diagnosed With ADHD in Childhood: A 16-year Longitudinal Study of Children With and Without ADHD.
The Many Channels of Screen Media Technology in ADHD: a Paradigm for Quantifying Distinct Risks and Potential Benefits.
Methylphenidate increases willingness to perform effort in adults with ADHD.
Driving the Point Home: Novel Approaches to Mitigate Crash Risk for Patients With ADHD.
A generic algorithm for sleep-wake cycle detection using unlabeled actigraphy dataRead Full Text
Cigarette Smoking Progression Among Young Adults Diagnosed With ADHD in Childhood: A 16-year Longitudinal Study of Children With and Without ADHD.
An Automated Text-Messaging Platform for Enhanced Retention and Data Collection in a Longitudinal Birth Cohort: Cohort Management Platform Analysis.
Eveningness diurnal preference associated with poorer socioemotional cognition and social functioning among healthy adolescents and young adults.
Pre-Pregnancy Weight and Symptoms of Attention Deficit Hyperactivity Disorder and Executive Functioning Behaviors in Preschool Children.
Associations between imprinted gene differentially methylated regions, appetitive traits and body mass index in children.
Editorial Perspective: Delayed circadian rhythm phase: a cause of late-onset attention-deficit/hyperactivity disorder among adolescents?
Moving Beyond Symptom Remission to Optimize Long-term Treatment of Attention-Deficit/Hyperactivity Disorder.
Validation of the Sleep Regularity Index in Older Adults and Associations with Cardiometabolic Risk.
Reliability and Validity of the Daily Parent Rating of Evening and Morning Behavior Scale, Revised.
Self-reported prenatal tobacco smoke exposure, AXL gene-body methylation, and childhood asthma phenotypes.
Sluggish Cognitive Tempo in Adults Referred for an ADHD Evaluation: A Psychometric Analysis of Self- and Collateral Report.
How Substance Users With ADHD Perceive the Relationship Between Substance Use and Emotional Functioning.
Associations between maternal cytokine levels during gestation and measures of child cognitive abilities and executive functioning.
SLEEPING AT HOME: FEASIBILITY AND TOLERABILITY OF AMBULATORY POLYSOMNOGRAPHY FOR USE WITH ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDERRead Full Text
Maternal pre-pregnancy obesity and child neurodevelopmental outcomes: a meta-analysis.
Childhood ADHD Symptoms and Future Illicit Drug Use: The Role of Adolescent Cigarette Use.
ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge.
Impact of Smoking Ban on Passive Smoke Exposure in Pregnant Non-Smokers in the Southeastern United States.
Proof-of-concept study of an at-home, engaging, digital intervention for pediatric ADHD.
Cannabinoid exposure and altered DNA methylation in rat and human sperm.
A Pilot Trial of Mindfulness Meditation Training for ADHD in Adulthood: Impact on Core Symptoms, Executive Functioning, and Emotion Dysregulation.
Environment and Gametic Epigenetic Reprogramming.Read Full Text
Maternal inflammatory diet and adverse pregnancy outcomes: Circulating cytokines and genomic imprinting as potential regulators?
Efficacy, Safety, and Tolerability of an Extended-Release Orally Disintegrating Methylphenidate Tablet in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder in the Laboratory Classroom Setting.
Prenatal Smoke Exposure and ADHD: Advancing the Field.
Sleep disturbances in adolescents with ADHD: A systematic review and framework for future research.
Topical Review: ADHD and Health-Risk Behaviors: Toward Prevention and Health Promotion.
"I Use Weed for My ADHD": A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD.
Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults.
Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up.
The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate, for Treatment of Attention-Deficit/Hyperactivity Disorder Symptoms: A Multicenter, Dose-Optimized, Double-Blind, Randomized, Placebo-Controlled Crossover Laboratory Classroom Study.
Mindfulness Meditation Training for Attention-Deficit/Hyperactivity Disorder in Adulthood: Current Empirical Support, Treatment Overview, and Future Directions.
PRE-PREGNANCY OBESITY AND OFFSPRING NEUROBEHAVIORAL DEVELOPMENTRead Full Text
Attention Deficit Hyperactivity Disorder symptoms and smoking trajectories: race and gender differences.
ADHD and smokingRead Full Text
An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults.
Dasotraline for the treatment of attention-deficit/hyperactivity disorder: A randomized, double-blind, placebo-controlled, proof-of-concept trial in adultsRead Full Text
Angiogenic, neurotrophic, and inflammatory system SNPs moderate the association between birth weight and ADHD symptom severity.
A randomized placebo-controlled double-blind study evaluating the time course of response to methylphenidate hydrochloride extended-release capsules in children with attention-deficit/hyperactivity disorder.
Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers.
Ecological momentary assessment of antecedents and consequences of smoking in adults with attention-deficit/hyperactivity disorder.
ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.
Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.
A pilot study of lis-dexamfetamine dimesylate (LDX/SPD489) to facilitate smoking cessation in nicotine-dependent adults with ADHD.
Smoking motivation in adults with attention-deficit/hyperactivity disorder using the Wisconsin inventory of smoking dependence motives.
Analysis of individual items on the attention-deficit/hyperactivity disorder symptom rating scale in children and adults: the effects of age and sex in pivotal trials of lisdexamfetamine dimesylate.
Combined ecological momentary assessment and global positioning system tracking to assess smoking behavior: a proof of concept study.
Childhood economic strains in predicting substance use in emerging adulthood: mediation effects of youth self-control and parenting practices.
Nicotinic receptor gene variants interact with attention deficient hyperactive disorder symptoms to predict smoking trajectories from early adolescence to adulthood.
Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD).
Individual- and community-level correlates of cigarette-smoking trajectories from age 13 to 32 in a U.S. population-based sample.
Effects of smoking abstinence on smoking-reinforced responding, withdrawal, and cognition in adults with and without attention deficit hyperactivity disorder.
COMBINED EMA AND GPS FOR ASSESSING THE SPATIAL DISTRIBUTION OF SMOKING BEHAVIOR: A PROOF OF CONCEPT STUDYRead Full Text
The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up.
Attention-deficit/hyperactivity disorder in adolescenceRead Full Text
ADHD in adolescenceRead Full Text
Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.
Emotion dysregulation and emotional impulsivity among adults with attention-deficit/hyperactivity disorder: Results of a preliminary studyRead Full Text
Assessing the role of attention-deficit/hyperactivity disorder symptoms in smokers with and without posttraumatic stress disorder.
Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder.
Efficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit/hyperactivity disorder.
Sex, ADHD symptoms, and smoking outcomes: an integrative model.
COMMUNITY AND INDIVIDUAL LEVEL SOCIAL CORRELATES OF SMOKING TRAJECTORIES FROM ADOLESCENCE TO ADULTHOODRead Full Text
An examination of differences in variables maintaining smoking behavior in adult smokers with and without attention-deficit/hyperactivity disorderRead Full Text
Dose response effects of lisdexamfetamine dimesylate treatment in adults with ADHD: an exploratory study.
A preliminary analysis of interactions between genotype, retrospective ADHD symptoms, and initial reactions to smoking in a sample of young adults.
Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.
Understanding the phenotypic structure of adult retrospective ADHD symptoms during childhood in the United States.
Genotype and ADHD symptoms interact to predict adolescents' early smoking experiences in an epidemiological sampleRead Full Text
Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway.
Self-Regulation of Emotion, Functional Impairment, and Comorbidity Among ChildrenWith AD/HD.
Smoking withdrawal symptoms are more severe among smokers with ADHD and independent of ADHD symptom change: results from a 12-day contingency-managed abstinence trial.
Cognitive enhancers for the treatment of ADHD.
Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD.
Association between attention-deficit/hyperactivity disorder symptoms and obesity and hypertension in early adulthood: a population-based study.
Reliability and validity of self- and other-ratings of symptoms of ADHD in adults.
Psychomotor functioning and alertness with guanfacine extended release in subjects with attention-deficit/hyperactivity disorder.
A double-blind, placebo-controlled study of atomoxetine in young children with ADHD.
The ATXN1 and TRIM31 genes are related to intelligence in an ADHD background: evidence from a large collaborative study totaling 4,963 subjects.
CorrigendumRead Full Text
Clonidine extended-release tablets for pediatric patients with attention-deficit/hyperactivity disorder.
Lisdexamfetamine dimesylate for the treatment of attention deficit hyperactivity disorder in adults with a history of depression or history of substance use disorder.
Erratum: alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.
Abuse potential of stimulant drugs used to treat ADHDRead Full Text
Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day.
Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD.
Smoking withdrawal modulates right inferior frontal cortex but not presupplementary motor area activation during inhibitory control.
Alpha-2 adrenergic receptors and attention-deficit/hyperactivity disorder.
Effects of guanfacine extended release on oppositional symptoms in children aged 6-12 years with attention-deficit hyperactivity disorder and oppositional symptoms: a randomized, double-blind, placebo-controlled trial.
Monetary incentives promote smoking abstinence in adults with attention deficit hyperactivity disorder (ADHD).
Subjective Effects of MethylphenidateRead Full Text
Genetic variants in SLC9A9 are associated with measures of attention-deficit/hyperactivity disorder symptoms in families.
Implications of extending the ADHD age-of-onset criterion to age 12: results from a prospectively studied birth cohort.
Effects of lisdexamfetamine dimesylate treatment for ADHD on growth.
Evaluating Dopamine Reward Pathway in ADHD: Clinical Implications (vol 302, pg 1084, 2009)Read Full Text
Evaluating dopamine reward pathway in ADHD: clinical implications.
A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder.
Effects of postnatal parental smoking on parent and teacher ratings of ADHD and oppositional symptoms.
Reinforcing and subjective effects of methylphenidate in adults with and without attention deficit hyperactivity disorder (ADHD).
Interactions between genotype and depressive symptoms on obesity.
Association between smoking and retrospectively reported attention-deficit/hyperactivity disorder symptoms in a large sample of new mothers.
Effects of smoking abstinence on reaction time variability in smokers with and without ADHD: an ex-Gaussian analysis.
SNPs in dopamine D2 receptor gene (DRD2) and norepinephrine transporter gene (NET) are associated with continuous performance task (CPT) phenotypes in ADHD children and their families.
Methylphenidate and amphetamine do not induce cytogenetic damage in lymphocytes of children with ADHD.
ADHD and smoking: from genes to brain to behavior.
Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.
ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines.
Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of pediatric ADHD patients treated with stimulant drugsRead Full Text
Efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorderRead Full Text
A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
Cognitive and sedative effects of guanfacine extended release in children and adolescents aged 6 to 17 years with attention-deficit/hyperactivity disorder: Safety and sleep effectsRead Full Text
Effects of smoking abstinence on adult smokers with and without attention deficit hyperactivity disorder: results of a preliminary study.
Genes implicated in serotonergic and dopaminergic functioning predict BMI categories.
Interactions between genotype and retrospective ADHD symptoms predict lifetime smoking risk in a sample of young adults.
Psychosocial treatments for preschool-aged children with Attention-Deficit Hyperactivity Disorder.
Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder.
Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood.
Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
Effectiveness of methylphenidate in the 10-month continuation phase of the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
Parent versus teacher ratings of attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
Increases in impulsivity following smoking abstinence are related to baseline nicotine intake and boredom susceptibility.
Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder.
ADHD and Sustance Abuse UpdateRead Full Text
Abuse liability of medications used to treat attention-deficit/hyperactivity disorder (ADHD).
Stimulant-related reductions of growth rates in the PATS.
Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD.
Safety and tolerability of methylphenidate in preschool children with ADHD.
Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS).
Pharmacogenetics of methylphenidate response in preschoolers with ADHD.
Genetic associations with reaction time variability in AD/HDRead Full Text
Psychometric properties of an adult ADHD diagnostic interview.
Evidence base for the use of stimulant medication in preschool children with ADHDRead Full Text
Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.
A pilot study of methylphenidate preference assessment in children diagnosed with attention-deficit/hyperactivity disorder.
Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults.
A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.
Assessing methylphenidate preference in ADHD patients using a choice procedure.
The genetics of AD/HD: Subtyping, comorbidity and developmental considerationsRead Full Text
A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).
Delay discounting is associated with substance use in college students.
Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
Sensitization to the cardiovascular but not subject-rated effects of oral cocaine in humans.
Assessing the abuse potential of methylphenidate in nonhuman and human subjects: a review.
Use and management of medications for children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD)Read Full Text
Use and management of medications for children diagnosed with Attention Deficit Hyperactivity Disorder (ADHD)Read Full Text
Use and management of medications for children diagnosed with attention deficit hyperactivity disorder (ADHD)Read Full Text
Temporal discounting: basic research and the analysis of socially important behavior.
Effects of methylphenidate on sensitivity to reinforcement in children diagnosed with attention deficit hyperactivity disorder: an application of the matching law.
The good, the bad, and the aggregate.
Effects of training dose on the relationship between discriminative-stimulus and self-reported drug effects of d-amphetamine in humans.
Factors affecting the reliability of clinical judgments about the function of children's school-refusal behavior.
Has behavior therapy drifted from its experimental roots? A survey of publication trends in mainstream behavioral journals.
Behavioural assessment of children and adolescents.
Quantitative integration of single-subject studies: Methods and misinterpretations.
Discriminative and participant-rated effects of methylphenidate in children diagnosed with attention deficit hyperactivity disorder (ADHD).
Comparison of acute behavioral effects of sustained-release and immediate-release methylphenidate.
Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.
Erratum to: Human sensitivity to reinforcement in operant choice: How much do consequences matter?Read Full Text
Human sensitivity to reinforcement in operant choice: How much do consequences matter?
Experimental analysis of childhood psychopathology: A laboratory matching analysis of the behavior of children diagnosed with Attention-Deficit Hyperactivity Disorder (ADHD)Read Full Text